AI in Healthcare: Progress in Drug Discovery but Challenges Remain
The integration of AI in healthcare, particularly in drug discovery, has shown promising advancements but also significant challenges. AI technologies have been used to design millions of potential compounds for diseases like Huntington's, yet none have received FDA approval. The pharmaceutical industry remains cautious, as AI has not improved clinical success rates despite speeding up preclinical timelines. Additionally, the use of AI chatbots in healthcare poses risks, with patient safety organizations warning against their unregulated use for medical advice. 
